Singapore, Singapore

Darren Shen Yon Toh

This inventor holds 1 USPTO granted patent. Top assignee: Singapore Health Services Pte Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Darren Shen Yon Toh. Retrieved from https://idiyas.com/inventor/darren-shen-yon-toh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Darren Shen Yon Toh

Introduction

Darren Shen Yon Toh is a notable inventor based in Singapore, SG. He has made significant contributions to the field of medical technology, particularly in the area of cancer treatment. His innovative approach has led to the development of a unique patent that addresses critical challenges in the medical field.

Latest Patents

Darren holds a patent titled "Method of Modulating Sensitivity to Tyrosine Kinase Inhibitor." This patent represents a significant advancement in the treatment of cancers that are resistant to conventional therapies. With 1 patent to his name, Darren's work is paving the way for more effective treatment options for patients.

Career Highlights

Darren is currently employed at Singapore Health Services Pte Ltd, where he continues to work on groundbreaking medical technologies. His role at the company allows him to collaborate with other experts in the field, enhancing the impact of his innovations.

Collaborations

Darren has worked alongside talented colleagues such as Daniel Shao-Weng Tan and Narayanan Gopalakrishna Iyer. Their combined expertise fosters a collaborative environment that drives innovation and research forward.

Conclusion

Darren Shen Yon Toh's contributions to medical technology through his patent and collaborative efforts highlight the importance of innovation in healthcare. His work exemplifies the potential for advancements that can significantly improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…